These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25339356)

  • 1. Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor.
    Stavrou EX; Fang C; Merkulova A; Alhalabi O; Grobe N; Antoniak S; Mackman N; Schmaier AH
    Blood; 2015 Jan; 125(4):710-9. PubMed ID: 25339356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.
    Fang C; Stavrou E; Schmaier AA; Grobe N; Morris M; Chen A; Nieman MT; Adams GN; LaRusch G; Zhou Y; Bilodeau ML; Mahdi F; Warnock M; Schmaier AH
    Blood; 2013 Apr; 121(15):3023-32. PubMed ID: 23386129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
    Fang C; Schmaier AH
    Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner.
    Barbieri SS; Amadio P; Gianellini S; Tarantino E; Zacchi E; Veglia F; Howe LR; Weksler BB; Mussoni L; Tremoli E
    Circulation; 2012 Sep; 126(11):1373-84. PubMed ID: 22865892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
    Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
    Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologic activities of the contact activation system.
    Schmaier AH
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin.
    Shariat-Madar Z; Mahdi F; Warnock M; Homeister JW; Srikanth S; Krijanovski Y; Murphey LJ; Jaffa AA; Schmaier AH
    Blood; 2006 Jul; 108(1):192-9. PubMed ID: 16514058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin-Angiotensin Systems.
    Schmaier AH
    Front Med (Lausanne); 2016; 3():61. PubMed ID: 27965959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vascular side of plasma kallikrein.
    Renné T
    Blood; 2015 Jan; 125(4):589-90. PubMed ID: 25614637
    [No Abstract]   [Full Text] [Related]  

  • 10. Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas.
    Peiró C; Vallejo S; Gembardt F; Palacios E; Novella S; Azcutia V; Rodríguez-Mañas L; Hermenegildo C; Sánchez-Ferrer CF; Walther T
    J Physiol; 2013 May; 591(9):2275-85. PubMed ID: 23459756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling.
    Iwai M; Nakaoka H; Senba I; Kanno H; Moritani T; Horiuchi M
    Hypertension; 2012 Jul; 60(1):137-44. PubMed ID: 22665126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
    Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
    Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin -induced vasodilatation: Role of age, ACE1-inhibitory peptide, mas- and bradykinin receptors.
    Siltari A; Korpela R; Vapaatalo H
    Peptides; 2016 Nov; 85():46-55. PubMed ID: 27628189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
    Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
    Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury.
    Wang L; Miller C; Swarthout RF; Rao M; Mackman N; Taubman MB
    Blood; 2009 Jan; 113(3):705-13. PubMed ID: 18931346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apold1 deficiency associates with increased arterial thrombosis in vivo.
    Diaz-Cañestro C; Bonetti NR; Wüst P; Nageswaran V; Liberale L; Beer JH; Montecucco F; Lüscher TF; Bohacek J; Camici GG
    Eur J Clin Invest; 2020 Feb; 50(2):e13191. PubMed ID: 31797367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
    Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
    Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.
    Silveira KD; Barroso LC; Vieira AT; Cisalpino D; Lima CX; Bader M; Arantes RM; Dos Santos RA; Simões-E-Silva AC; Teixeira MM
    PLoS One; 2013; 8(6):e66082. PubMed ID: 23762470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system.
    Biswas N; Maihofer AX; Mir SA; Rao F; Zhang K; Khandrika S; Mahata M; Friese RS; Hightower CM; Mahata SK; Baker DG; Nievergelt CM; Vaingankar SM; O'Connor DT
    BMC Med Genet; 2016 Mar; 17():21. PubMed ID: 26969407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of AT1 and Mas receptors in the modulation of inflammatory pain.
    Costa AC; Romero TR; Pacheco DF; Perez AC; Savernini A; Santos RR; Duarte ID
    Peptides; 2014 Nov; 61():17-22. PubMed ID: 25169953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.